skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Pharmacotherapy of panic disorder

Review

(2571) Views  (616) Full article downloads

Authors: Charles B Pull, Cristian Damsa

Published Date September 2008 Volume 2008:4(4) Pages 779 - 795
DOI: http://dx.doi.org/10.2147/NDT.S1224

Charles B Pull1, Cristian Damsa2

1Department of Neurosciences, Centre Hospitalier de Luxembourg, Luxembourg; 2Department of Psychiatry, Clinical Investigation Program, University of Colorado Health Sciences Center, USA

Abstract: Panic disorder (PD) is a common, persistent and disabling mental disorder. It is often associated with agoraphobia. The present article reviews the current status of pharmacotherapy for PD with or without agoraphobia as well as the current status of treatments combing pharmacotherapy with cognitive behavior therapy (CBT). The review has been written with a focus on randomized controlled trials, meta-analyses, and reviews that have been published over the past few years. Effective pharmacological treatments include tricyclic antidepressants, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and various benzodiazepines. Treatment results obtained with CBT compare well with pharmacotherapy, with evidence that CBT is at least as effective as pharmacotherapy. Combining pharmacotherapy with CBT has been found to be superior to antidepressant pharmacotherapy or CBT alone, but only in the acute-phase treatment. Long term studies on treatments combining pharmacotherapy and CBT for PD with or without agoraphobia have found little benefit, however, for combination therapies versus monotherapies. New investigations explore the potential additional value of sequential versus concomitant treatments, of cognitive enhancers and virtual reality exposure therapy, and of education, self management and Internet-based interventions.

Keywords: Panic disorder, agoraphobia, pharmacotherapy, cognitive-behavioral therapy, combination treatments.








Readers of this article also read:

Tipifarnib in the treatment of acute myeloid leukemia
Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Periosteoplasty for covering gingival recessions: Clinical results
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Erratum
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Duloxetine in the management of diabetic peripheral neuropathic pain
Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?